Page last updated: 2024-12-09

6-o-(n-heptylcarbamoyl)methylglucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

6-O-(N-heptylcarbamoyl)methylglucoside: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2733955
SCHEMBL ID60345
MeSH IDM0168177

Synonyms (30)

Synonym
alpha-d-glucopyranoside, methyl, 6-(heptylcarbamate)
6-o-(n-heptylcarbamoyl)methylglucoside
115457-83-5
unii-72l66t594h
72l66t594h ,
6-o-(n-heptylcarbamoyl)methyl-alpha-d-glucopyranoside
hecameg
methyl 6-o-(n-heptylcarbamoyl)-alpha-d-glucopyranoside, >=97.0% (tlc)
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-methoxyoxan-2-yl]methyl n-heptylcarbamate
SCHEMBL60345
AKOS024375418
.alpha.-d-glucopyranoside, methyl, 6-(heptylcarbamate)
6-o-(n-heptylcarbamoyl)-methyl-.alpha.-d-glucopyranoside
methyl-.alpha.-d-glucopyranoside 6-(heptylcarbamate)
hecameg [mi]
6-o-(n-heotylcarbamoyl)-methyl-alpha-d-glucopyranoside
mfcd00077425
DTXSID00151107
methyl 6-o-(n-heptylcarbamoyl)-i+/--d-glucopyranoside
methyl 6-o-(n-heptylcarbamoyl)-alpha-d-glucopyranoside
methyl-6-o-(n-heptylcarboxyl)-a-d-glucopyranoside
AS-67710
methyl-alpha-d-glucopyranoside 6-(heptylcarbamate)
CS-0256375
a-d-glucopyranoside,methyl,6-(heptylcarbamate)
((2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-methoxytetrahydro-2h-pyran-2-yl)methyl heptylcarbamate
Q27266084
A893870
6-o-(n-heptylcarbamoyl)-methyl-a-d-glucopyranoside
HY-W250182
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.35 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]